Article

PD-L1 Tumor Cell Expression in Upper Tract Urothelial Carcinomas is Associated with Higher Pathological Stage

2020-04-17

Abstract excerpt

<h4>Background: </h4> Upper tract urothelial carcinomas (UTUCs) are a rare and unique subset of urothelial carcinoma (UC). Immune checkpoint inhibitors are showing promise in the treatment of UC of the bladder and UTUC alike. While several large studies have looked at PD-L1 expression in UC in general, most have not investigated UTUC as a separate group. Moreover, comparison between studies of PD-L1 expression is...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1e5d0beb-a0d3-5d82-9f9a-10b30c86573c
DOI: 10.21203/rs.3.rs-22868/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

PD-L1 Tumor Cell Expression in Upper Tract Urothelial Carcinomas is Associated with Higher Pathological StageDOI 10.21203/rs.3.rs-22868/v1Read

A Case Series: High PD-L1 Expression and Postoperative Immunotherapy Response in Four Cases of Sarcomatoid Urothelial CarcinomaSemantic proximity Read

PD-L1 expression in Advanced Urothelial Carcinomas in two reference institutions in Colombia.Semantic proximity Read

Tumor immune microenvironment and clinical outcomes in stage IV urothelial cancer: YODO study.Semantic proximity Read

Clinicopathological characteristics, molecular landscape, and biomarker landscape for predicting the efficacy of PD-1/PD-L1 inhibitors in Chinese population with mismatch repair deficient urothelial carcinoma: a real-world studySemantic proximity Read

Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers.Semantic proximity Read

Evaluation of PD-L1 and other immune markers in bladder urothelial carcinoma stratified by histologic variants and molecular subtypes.Semantic proximity Read

PD-L1 expression and its correlation with tumor biomarkers in Chinese urothelial bladder cancer.Semantic proximity Read

Comprehensive Comparison of Somatic, Germline, and Immune Cell Profiles in Upper Tract and Bladder Urothelial CarcinomaSemantic proximity Read

Oncogenic PIK3CA mutation enhances tumor immunogenicity through the IRF1-NLRC5-MHC-I axis in urothelial carcinoma.Semantic proximity Read

PD-L1 expression and FGFR-mutations among Danish patients diagnosed with metastatic urothelial carcinoma: A retrospective and descriptive study.Semantic proximity Read

Epigenetic modulation elicits an NK cell-mediated immune response in urothelial carcinomaSemantic proximity Read

Programmed Death Cell Ligand-1 Expression in Lymphoepithelioma-like Carcinoma of the Bladder: A Case ReportSemantic proximity Read